📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: IsoRay

1.1 - Company Overview

IsoRay Logo

IsoRay

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of state-of-the-art, personalized brachytherapy products that offer more cost-effective cancer treatment, utilizing a unique isotope for the treatment of both common and difficult-to-treat cancers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to IsoRay

Storm Therapeutics Logo

Storm Therapeutics

HQ: United Kingdom Website
  • Description: Provider of RNA-modifying enzyme–targeted therapeutics and discovery platforms, including STC-15, an oral METTL3 inhibitor for oncology; a drug discovery and RNA analytics platform to identify targets and develop small-molecule candidates for oncology, inflammation, viral infections, and CNS diseases; and a target discovery platform using chemical biology, RNA sequencing, RNA mass spectrometry, and functional genomics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Storm Therapeutics company profile →
IGM Biosciences Logo

IGM Biosciences

HQ: United States Website
  • Description: Provider of a proprietary, clinical-stage IgM antibody platform developing engineered IgM therapeutics for cancer, autoimmune and inflammatory diseases. Pipeline includes imvotamab (CD20xCD3) for autoimmune diseases, aplitabart (DR5) for colorectal cancer, and IGM-2644 (CD38xCD3) for autoimmune diseases, all in early trials. Also offers an expanded access program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IGM Biosciences company profile →
Suros Surgical Logo

Suros Surgical

HQ: United States Website
  • Description: Provider of award-winning, Indiana-based medical devices enabling minimally invasive tissue excision and biopsy across multiple surgical specialties, built on patented surgical platform technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Suros Surgical company profile →
Scorpion Therapeutics Logo

Scorpion Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage precision oncology therapeutics, developing small-molecule inhibitors targeting the H1047X-mutant PI3Kα in solid tumors (STX-H1047-PI3Kα) and exon 20 insertion mutations in EGFR driving non-small cell lung cancer (STX-EGFR-EXON20).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scorpion Therapeutics company profile →
Aurealis Therapeutics Logo

Aurealis Therapeutics

HQ: Finland Website
  • Description: Provider of cell and gene therapies for chronic wounds and complex inflammatory diseases. Its four-in-one biologic AUP-16 is a genetically engineered Lactococcus cremoris producing therapeutic proteins to halt inflammation, induce blood vessel growth, and promote tissue formation for diabetic foot, venous leg, and pressure ulcers. AUP-55 is in pre-clinical development for ovarian and bladder cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aurealis Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for IsoRay

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to IsoRay

2.2 - Growth funds investing in similar companies to IsoRay

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for IsoRay

4.2 - Public trading comparable groups for IsoRay

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to IsoRay

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About IsoRay

What does IsoRay do?

IsoRay is a provider of state-of-the-art, personalized brachytherapy products that offer more cost-effective cancer treatment, utilizing a unique isotope for the treatment of both common and difficult-to-treat cancers.

Who are IsoRay's competitors?

IsoRay's competitors and similar companies include Storm Therapeutics, IGM Biosciences, Suros Surgical, Scorpion Therapeutics, and Aurealis Therapeutics.

Where is IsoRay headquartered?

IsoRay is headquartered in United States.

How many employees does IsoRay have?

IsoRay has 1,000 employees 🔒.

When was IsoRay founded?

IsoRay was founded in 2010 🔒.

What sector and industry vertical is IsoRay in?

IsoRay is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for IsoRay

Who are the top strategic acquirers in IsoRay's sector and industry

Top strategic M&A buyers and acquirers in IsoRay's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for IsoRay?

Top strategic M&A buyers groups and sectors for IsoRay include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in IsoRay's sector and industry vertical

Which are the top PE firms investing in IsoRay's sector and industry vertical?

Top PE firms investing in IsoRay's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in IsoRay's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in IsoRay's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in IsoRay's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to IsoRay include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in IsoRay's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for IsoRay?

The key public trading comparables and valuation benchmarks for IsoRay include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for IsoRay for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for IsoRay with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in IsoRay's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for IsoRay with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in IsoRay's' sector and industry vertical?

Access recent funding rounds and capital raises in IsoRay's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for IsoRay